The table below shows PTC THERAPEUTICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$59.04M
$870.10M
$70.76M
-$29.49M
-$97.40M
-$100.16M
Capital expenditure
$1.20M
$1.72M
$9.59M
$10.27M
$9.31M
$5.67M
Investing cash flow
-$93.74M
-$184.36M
-$114.93M
-$28.97M
$49.04M
$30.15M
Dividends paid
-
-
-
PTCT operating cash flow (10-K history)
PTC THERAPEUTICS, INC. reported operating cash flow of $711.20M for fiscal year 2025. That is up 760.4% from -$107.69M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$103.57M (FY 2016) to $711.20M. Figures come from the company's audited annual reports as filed with the SEC.
